Abstract:Background. Hepatocellular carcinoma (HCC) is recognized as the fourth in incidence and the third in mortality worldwide. The onset of HCC is insidious and often asymptomatic at the early stage. HCC is more prone to metastasis, recurrence, and drug resistance than other solid tumors owing to its feature of high heterogeneity. Therefore, what particularly important is to search for effective molecular markers in the occurrence and progression of HCC. Aim. To probe into the therapeutic potential of circACTG1 (hsa_circ_0046144) in HCC cell migration and invasion, providing a new insight and molecular target to diagnose and cure HCC patients. Methods. The circACTG1 expression in collected HCC cells was determined by quantitative polymerase chain reaction (qPCR). Assessment for circACTG1 diagnosing capability was analyzed by receiver operating characteristic (ROC) curves. Transwell assay, wound healing assay, and cell counting kit-8 assay were used for monitoring the effect of circACTG1 in HCC cell invasion, migration, and proliferation, respectively; qPCR, luciferase reporter assay, databases, and Western blot analysis were used for identifying the modulation mechanisms among circACTG1, miRNA-940, and RIF1. What is more, our study verified AKT-mTOR signaling after miR-940 mimic treatment or circACTG1 knockdown. Results. circACTG1 was overexpressed in HCC cells and tissues. Knockdown of circACTG1 restrained 97H and Huh7 cell migration and invasion. Significantly, circACTG1 was discovered to serve as a miR-940 sponge. miR-940 activation rebated the circACTG1 level, and conversely, miR-940 inhibition boosted the circACTG1 level. However, this effect or relationship was not seen after circACTG1 mutation. Furtherly, miR-940-downregulated expression was also found in HCC patients, and importantly, miR-940 inhibition reversed circACTG1 expression in 97H cells with circACTG1 knockdown. Moreover, the expression of RIF1 was significantly reduced after inhibiting circACTG1 or overexpressing miR-940 but rescued when both circACTG1 and miR-940 were inhibited. Finally, circACTG1 and miR-940 played significant roles of regulating AKT-mTOR signaling. Conclusion. circACTG1 expression remarkably ascended in HCC, which is of certain diagnostic value. Moreover, circACTG1 potentially regulates HCC cell proliferation, invasion, and migration via miR-940/RIF1/AKT/mTOR pathway.

Alpha1-ACT Functions As a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway Via Activation of PTEN

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

ACTN1 Supports Tumor Growth by Inhibiting Hippo Signaling in Hepatocellular Carcinoma

Targeted Inhibition of ACK1 Can Inhibit the Proliferation of Hepatocellular Carcinoma Cells Through the PTEN/AKT/mTOR Pathway.

Metallothionein 1H (MT1H) Functions As a Tumor Suppressor in Hepatocellular Carcinoma Through Regulating Wnt/β-catenin Signaling Pathway

Expression and Clinical Significance of TAp73α, P53, PCNA and Apoptosis in Hepatocellular Carcinoma

Antitumor Effect of Tyrosine Kinase Inhibitor, AMN107, in Hepatocellular Carcinoma

ANGPTL1 Interacts with Integrin Α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.

Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma.

Expression of PTEN in hepatocellular carcinoma and its relationship with p53, cell proliferation and apoptosis

Glutathione S-transferase A1 Suppresses Tumor Progression and Indicates Better Prognosis of Human Primary Hepatocellular Carcinoma

ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/-Catenin Signaling

MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.

Inhibited the activity of PTEN by α-Fetoprotein caused resistance to all trans retinoic acid of hepatoma cells

Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.

Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Acts As a Tumor Suppressor in Hepatocellular Carcinoma

Tumour-suppressive Role of PTPN13 in Hepatocellular Carcinoma and Its Clinical Significance

circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway

ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression

Tumor-suppressive Role of HACE1 in Hepatocellular Carcinoma and Its Clinical Significance.

The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma